Ophthalmology Therapeutics: Does current pipeline innovation hold the potential to affect the future ophthalmology market?

This Frontier Pharma: Ophthalmology Therapeutics assesses first-in-class innovation in the ophthalmology pipeline, highlighting key trends in the distribution of these products.

Pune, India - March 14, 2018 /MarketersMedia/ —

The pipeline is varied in terms of molecular targets and molecule types. Products acting on the immune system and neurotransmitter signaling are the most prevalent, but no single target dominates by any clear margin. There are a total of 194 first-in class pipeline products in development for ophthalmologic indications 38% of the 512 pipeline products for which there is a disclosed molecular target. Encompassing gene therapies, slowing of the visual cycle and antisense therapies, the pipeline appears robust and has huge potential to strengthen treatment options for ophthalmological disorders.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs

Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis and prognosis, and the treatment options available.
• Visualize the composition of the ophthalmological disorders market in terms of dominant molecule types and targets, and understand the current unmet needs and how they can be addressed. This knowledge allows a competitive understanding of gaps in the market.
• Analyze the ophthalmological disorders pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating ophthalmological disorders to overcome the overwhelming level of unmet need.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
• Identify commercial opportunities in the ophthalmological disorders deals landscape by analyzing trends in licensing and co-development deals, and a curated list of ophthalmological disorder therapies that have not yet been involved in deals, and may offer potential investment opportunities.

Get this report at: https://www.themarketreports.com/report/buy-now/935550

In the past the ophthalmological disorders therapy area has suffered from a lack of full understanding of the pathophysiology and underlying mechanisms of the diseases. However, as this knowledge has improved vastly in recent years, potential targets have been identified for treatment. As well as the main disorders previously mentioned, there is also interest in developing treatments for indications such as allergic conjunctivitis and retinitis pigmentosa. The approval of a gene therapy for retinitis pigmentosa is indicative of this progress, and represents the first gene therapy approved for an inherited condition by the FDA.

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935550

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/ophthalmology-therapeutics-does-current-pipeline-innovation-hold-the-potential-to-affect-the-future-ophthalmology-market/314326

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs%20%20

Source: MarketersMedia

Release ID: 314326

More News From Daily Sports Club

Cristiano Ronaldo expected to play for Juventus on Saturday

Oct 19, 2018

MILAN — Cristiano Ronaldo's return to Juventus started with a selfie, included a goal in a practice game, and will likely end up with a starring role on Saturday. Ronaldo, who has been accused of rape and is facing a civil lawsuit in the United States, had the weekend off while his Italian team was idle during a break for international matches. Normally the star of his national team, the 33-year-old Ronaldo was left off Portugal's squad for games against Poland and Scotland. The team won both anyway. But he's back now, and is expected to be in the lineup...

Former swim champion Magnini's doping decision postponed

Oct 19, 2018

ROME — Two-time swimming world champion Filippo Magnini will have to wait longer to find out his fate in a doping case for which he risks a ban of eight years. Magnini appeared before a court of Italy's anti-doping agency on Monday, but at the end of a four-hour hearing judges ruled additional time was needed and postponed their decision to Nov. 6. "I simply recounted the truth and now I'm calm. I am totally innocent," said the 36-year-old Magnini, who retired last year. "I'm happy because my lawyers managed to bring out the truth. The sentence was postponed because...

Father of Kompany elected mayor of Brussels municipality

Oct 19, 2018

BRUSSELS — The father of Belgium defender Vincent Kompany will become mayor of a Brussels municipality after his party won Sunday's elections. The Manchester City defender says in a video message that his father is the "first black mayor in Belgium — ever" before erupting in cheers. Pierre Kompany, who came from the former Belgian colony Congo, and his party agreed to a coalition with two other groups to take over in Ganshoren, a town of about 25,000 people which is part of the Brussels region. ___ More AP soccer: https://apnews.com/tag/apf-Soccer and https://twitter.com/AP_Sports

Italy leaves it late to earn 1st competitive win in a year

Oct 19, 2018

ROME — Italy is finally showing signs of emerging from its crisis, nearly a year after failing to qualify for the World Cup. Cristiano Biraghi's goal in stoppage time earned the Azzurri a much-needed 1-0 win in Poland on Sunday in the UEFA Nations League. Playing in Group 3 of League A, Poland became the first team to be relegated in the new European competition. Italy also hit the crossbar twice in the first half, first with Jorginho then with Lorenzo Insigne. Still, the match appeared headed for a scoreless draw until Biraghi slid in to redirect a corner inside...

French rider Pinot wins Tour of Lombardy

Oct 19, 2018

COMO, Italy — French rider Thibaut Pinot won the Tour of Lombardy on Saturday for the first single-day classic victory of his career. Pinot, who rides for the Groupama-FDJ team, left behind challenger Vincenzo Nibali with a solo attack 14 kilometers from the finish of the hilly 241-kilometer (150-mile) route from Bergamo to Como. Nibali, a two-time winner of the Lombardy race, finished second, 32 seconds behind. Dylan Teuns of Belgium crossed third, 43 seconds back. The victory caps a strong week for Pinot, who also won the Milano-Torino race on Wednesday. "Among the monuments (single-day classics), Il Lombardia is...

Search

About Us

From transfer news, tactical analysis to predictions, get only the best of the world of sports daily with Daily Sports Club.

Contact us: sales[at]dailysportsclub.com

Subscribe Now!